| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Canadian Journal of Anesthesia, Vol 42, 64-68, Copyright © 1995 by Canadian Anesthesiologists' Society
ARTICLES |
U Schott and E Bjorsell-Ostling
Department of Anesthesia and Intensive Care, Orebro Medical Center Hospital, Sweden.
On the basis of a patient with fulminant meningococcaemia and severe disseminated intravascular coagulation (DIC) syndrome, the diagnostic potential of a clot impedance test - Sonoclot coagulation analysis - was used to evaluate plasma exchange. A 17-yr-old girl was treated for a fulminant infection with Neisseria meningitidis in our intensive care unit. She developed severe DIC. Whereas platelet administration caused immediate arterial oxygen desaturation necessitating ventilatory support, plasma exchange improved pulmonary and mental function. Three separate exchanges all improved haemostasis. Sonoclot analysis was used together with routine coagulation analyses to evaluate this DIC treatment. Sonoclot signs, such as lack of the shoulder and peak, prolonged shoulder-peak interval and peak time predicted clinical bleeding manifestations (haematuria, haemoptysis, epistaxis) and were improved by platelet transfusion and plasma exchange. Plasma exchange was successful even at a very low platelet count of < 23 x 10(9).L-1. Sonoclot coagulation analyses were normalised several days before routine coagulation analyses. The Sonoclot gave additional information to routine coagulation studies, correctly indicated insufficient haemostasis and predicted a positive outcome. Also, plasma exchanges and platelet transfusions could be controlled in the management of DIC.
This article has been cited by other articles:
![]() |
F. Forestier, S. Belisle, C. Contant, F. Harel, G. Janvier, and J.-F. Hardy Reproductibilite et interchangeabilite du Thromboelastographe(R), Sonoclot(R) et du temps de coagulation active (Hemochron(R)), en chirurgie cardiaque : [Reproducibility and interchangeability of the Thromboelastograph(R), Sonoclot(R) and Hemochron(R) activated coagulation time in cardiac surgery] Can J Anesth, October 1, 2001; 48(9): 902 - 910. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. Pivalizza, P. J. Pivalizza, S. Kee, L. I. Gottschalk, P. Szmuk, and D. C. Abramson Sonoclot Analysis in Healthy Children Anesth. Analg., April 1, 2001; 92(4): 904 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. van Deuren, P. Brandtzaeg, and J. W. M. van der Meer Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management Clin. Microbiol. Rev., January 1, 2000; 13(1): 144 - 166. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Konrad, T. Markl, G. Schuepfer, H. Gerber, and M. Tschopp The Effects of In Vitro Hemodilution with Gelatin, Hydroxyethyl Starch, and Lactated Ringer’s Solution on Markers of Coagulation: An Analysis Using SONOCLOTTM Anesth. Analg., March 1, 1999; 88(3): 483 - 483. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |